Company Filing History:

Years Active: 1999-2001
Title: The Innovative Contributions of Dale Alan McPhee
Introduction
Dale Alan McPhee, an accomplished inventor based in Melbourne, Australia, has made significant strides in the field of therapeutic compounds. With a passion for research and innovation, McPhee holds two patents that reflect his commitment to advancing medical science.
Latest Patents
One of McPhee's noteworthy inventions is focused on therapeutic compounds related to a biologically-active peptide fragment of the Nef protein of the human immunodeficiency virus (HIV). His invention includes pharmaceutical compositions that utilize these peptides or their biologically-active analogues, as well as antagonists of the peptides. Furthermore, McPhee has developed several pharmaceutical compositions comprising these antagonists and has outlined therapeutic and screening methods that employ the compounds and compositions of his invention.
Career Highlights
Throughout his career, Dale Alan McPhee has been associated with reputable institutions such as the Biomolecular Research Institute Ltd. and the Macfarlane Burnet Centre for Medical Research at Fairfield Hospital. His work within these organizations has furthered research in the medical field, focusing on innovative solutions to combat serious health challenges.
Collaborations
McPhee has collaborated with skilled professionals, including coworkers Ahmed Abdullah Azad and Cyril C Curtain. These partnerships have enriched his research endeavors, fostering an environment of innovation and shared knowledge crucial for success in the field of medical research.
Conclusion
Dale Alan McPhee's contributions to the field of therapeutic compounds underscore the importance of innovation in medical research. His patents reflect a deep understanding of complex biological processes and a commitment to developing effective treatments for challenging diseases. As he continues to contribute to scientific knowledge, McPhee remains a vital figure in the realm of inventions and innovations.